Update information
November 2013: This guidance has been partially updated by NICE technology appraisal guidance on peginterferon alfa and ribavirin for treating chronic hepatitis C in children and young people (TA300).
September 2010: This guidance has been partially updated by NICE technology appraisal guidance on peginterferon alfa and ribavirin for the treatment of chronic hepatitis C (TA200).
August 2006: This guidance is extended by NICE technology appraisal guidance on hepatitis C – peginterferon alfa and ribavirin (TA106).
ISBN: 978-1-4731-6982-1